Cover Image

Role of NMDA receptor GluN2D subunit in the antidepressant effects of enantiomers of ketamine

We investigated the rapid and sustained antidepressant effects of enantiomers of ketamine in N-methyl-d-aspartate (NMDA) receptor GluN2D subunit knockout (GluN2D-KO) mice. Intraperitoneal administration of ketamine or its enantiomers 10 min before the tail-suspension test exerted significant antidep...

Full description

Saved in:

Bibliographic Details
Main Authors:	Soichiro Ide (Author), Yuiko Ikekubo (Author), Masayoshi Mishina (Author), Kenji Hashimoto (Author), Kazutaka Ikeda (Author)
Format:	Book
Published:	Elsevier, 2017-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dynamic regulation of phosphorylation of NMDA receptor GluN2B subunit tyrosine residues mediates ketamine rapid antidepressant effects
by: Ke Wang, et al.
Published: (2024)

The role of GluN2A and GluN2B NMDA receptor subunits in AgRP and POMC neurons on body weight and glucose homeostasis
by: Aykut Üner, et al.
Published: (2015)

Identification of a Subtype-Selective Allosteric Inhibitor of GluN1/GluN3 NMDA Receptors
by: Yue Zeng, et al.
Published: (2022)

The Selective NMDA Receptor GluN2B Subunit Antagonist CP-101,606 with Antidepressant Properties Modulates Cytochrome P450 Expression in the Liver
by: Ewa Bromek, et al.
Published: (2021)

GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases
by: Amany Digal Ladagu, et al.
Published: (2023)

Silencing of the GluN1-NMDA Glutamate Receptor Subunit by Intranasal siRNA Increases the Latency Time for Seizures in the Pilocarpine Rodent Model of Epilepsy
by: Raphaela Gonçalves Barros Perri, et al.
Published: (2022)

Discovery of GluN2A subtype-selective N-methyl-d-aspartate (NMDA) receptor ligands
by: Liyang Jiang, et al.
Published: (2024)

GluN2B but Not GluN2A for Basal Dendritic Growth of Cortical Pyramidal Neurons
by: Steffen Gonda, et al.
Published: (2020)

Neuroprotection by chotosan, a Kampo formula, against glutamate excitotoxicity involves the inhibition of GluN2B-, but not GluN2A-containing NMDA receptor-mediated responses in primary cultured cortical neurons
by: Sachie Sasaki-Hamada, et al.
Published: (2017)

Absence of methamphetamine‐induced conditioned place preference in weaver mutant mice
by: Yuiko Ikekubo, et al.
Published: (2020)

Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity
by: Douglas Bledsoe, et al.
Published: (2017)

Imprecision in Precision Medicine: Differential Response of a Disease-Linked GluN2A Mutant to NMDA Channel Blockers
by: Jenna R. Gale, et al.
Published: (2021)

Homer2 deletion alters dendritic spine morphology but not alcohol-associated adaptations in GluN2B-containing NMDA receptors in the nucleus accumbens
by: Natalie S McGuier, et al.
Published: (2015)

The Glutathione Metabolite γ-Glutamyl-Glutamate Partially Activates Glutamate NMDA Receptors in Central Neurons With Higher Efficacy for GluN2B-Containing Receptors
by: Fatiha Sebih, et al.
Published: (2022)

Anticonvulsant Action of GluN2A-Preferring Antagonist PEAQX in Developing Rats
by: Pavel Mares, et al.
Published: (2021)

Analysis of M4 Transmembrane Segments in NMDA Receptor Function: A Negative Allosteric Modulatory Site at the GluN1 M4 is Determining the Efficiency of Neurosteroid Modulation
by: Kai Langer, et al.
Published: (2021)

A molecular perspective on mGluR5 regulation in the antidepressant effect of ketamine
by: Ola Sobhy A. Elmeseiny, et al.
Published: (2024)

Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by Using Network Pharmacology and Molecular Docking
by: Glorister A. Altê, et al.
Published: (2023)

Reward‐enhancing effect of methylphenidate is abolished in dopamine transporter knockout mice: A model of attention‐deficit/hyperactivity disorder
by: Soichiro Ide, et al.
Published: (2018)

Targeting GluN2B/NO Pathway Ameliorates Social Isolation-Induced Exacerbated Attack Behavior in Mice
by: Weiqing Fang, et al.
Published: (2021)

Development and Validation of [<sup>3</sup>H]OF-NB1 for Preclinical Assessment of GluN1/2B Candidate Drugs
by: Hazem Ahmed, et al.
Published: (2022)

A novel fluorescent labeling compound for GluN2A containing N-methyl-d-aspartate receptors identified by autodisplay-based screening
by: Alexander Dombovski, et al.
Published: (2024)

Investigating the L-Glu-NMDA receptor-H2S-NMDA receptor pathway that regulates gastric function in rats' nucleus ambiguus
by: Hongzhao Sun, et al.
Published: (2024)

The GluN2B-Selective Antagonist Ro 25-6981 Is Effective against PTZ-Induced Seizures and Safe for Further Development in Infantile Rats
by: Pavel Mareš, et al.
Published: (2021)

<i>Gelidium amansii</i> Attenuates Hypoxia/Reoxygenation-Induced Oxidative Injury in Primary Hippocampal Neurons through Suppressing GluN2B Expression
by: Md. Abdul Hannan, et al.
Published: (2020)

Roles of the AMPA receptor subunit GluA1 but not GluA2 in synaptic potentiation and activation of ERK in the anterior cingulate cortex
by: Sprengel Rolf, et al.
Published: (2009)

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
by: Caroline Ann Browne, et al.
Published: (2013)

Antidepressant-Like Effect of Venlafaxine Is Abolished in μ-Opioid Receptor-Knockout Mice
by: Soichiro Ide, et al.
Published: (2010)

NMDA Receptor Glycine Binding Site Modulators for Prevention and Treatment of Ketamine Use Disorder
by: Yu-Chin Hsiao, et al.
Published: (2023)

Decreased bone mineral density in ovariectomized mice is ameliorated after subsequent repeated intermittent administration of (R)‐ketamine, but not (S)‐ketamine
by: Yuko Fujita, et al.
Published: (2020)

Ketamine - precursor of a new generation antidepressant drugs
by: Jolanta Barbara Zawilska, et al.
Published: (2024)

Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant
by: Songbai Xu, et al.
Published: (2022)

Exploring the multifaceted potential of (R)-ketamine beyond antidepressant applications
by: Senbing Zhang, et al.
Published: (2024)

Th17 Cells in Depression: Are They Crucial for the Antidepressant Effect of Ketamine?
by: Meiying Cui, et al.
Published: (2021)

NR2 subunits and NMDA receptors on lamina II inhibitory and excitatory interneurons of the mouse dorsal horn
by: MacDermott Amy B, et al.
Published: (2010)

Ketamine and Active Ketamine Metabolites Regulate STAT3 and the Type I Interferon Pathway in Human Microglia: Molecular Mechanisms Linked to the Antidepressant Effects of Ketamine
by: Ming-Fen Ho, et al.
Published: (2019)

Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
by: Dmitriy Matveychuk, et al.
Published: (2020)

Association of plasma VEGF levels and the antidepressant effects of ketamine in patients with depression
by: Wei Zheng, et al.
Published: (2021)

Involvement of Tyr1472 phosphorylation of NMDA receptor NR2B subunit in postherpetic neuralgia in model mice
by: Unezaki Sawako, et al.
Published: (2012)

Ketamine Revisited New Insights into NMDA Inhibitors
Published: (2022)